In the future20 Jul 2023 13:07
Just my thoughts on what we could have news on in the short to mid term future based on people comments and research posted on this board recently:
* IB zero for gallium free imagery and cost and environmental benefits should be submitted for FDA approval soon
* phase 2 trial possibly in conjunction with another drug, metformin?
* possibly miss out phase 3 via the promising pathway act and go straight to market
* possibly apply for “Rare Pediatric Disease Priority Review Vouchers” and the tax credit benefits
* IB Trax was the main focus previously as we were due and update in Q2, so we should be informed of that soon
* IB nimble could it be adopted by other medical facilities
* Partnership with Prism
* Our products being offered on 2 medical sales sites eg Bayer, we haven’t heard back yet how they are progressing.
I am sure I have probably missed things out as well.
Trek, the next time you talk to Mike I would love to know his thoughts on where we stand with the points I have made above.
Any way just my ramblings based on people’s comments (thank you)
Thanks